angel investors, funding groups, individuals

Ladies and gentlemen, please allow me to make this assumption. I am assuming that you don't and won't make investments rashly or without plenty of pertinent information. Also, I believe that with each investment, go the hopes that the investment will result in a ''home run.''. Needless to say, home runs don't occur often and the last ''home run'' to come down the medical device pipeline was the Coronary Stent and our device/system will overshadow the Stent in both impact and in financial return. I can comfortably make this claim, because if you don't get a Stent you could and quite often die.  It is not the case with SUI - Severe Urinary Incontinence. SUI seldom results in mortality.  the number of needy and qualified patients continues to grow as they stack up year after year, decade after decade, as they have for the past 40+years  (I am a 47 year severe incontinence sufferer and I know that this statement is correct) to a staggering number approaching 14,500.000 sufferers. In addition, with the ''Graying of America'', the constant yearly increase in Alzheimer's, Dementia, Prostrate Cancer, MS, Parkinson's, TBI- Traumatic Brain Injuries, SCI- Spinal Cord Injuries and the ravages of war the afore-mentioned staggering number will dramatically INCREASE and could even become untenable and swamp our overburdened medical system.  It will surely adversely affect everyone in our country.

We have established a need, we offer an ever increasing patient demographic and now permit us to deliver a motivated purchasing population. First of all, the government entitlement programs of Medicare,  Medicaid etc spend over $314 billion per year, warehousing people in nursing homes.  since urinary incontinence is the #2 reason why  people enter nursing homes, the amount spent on incontinence is ever increasing with no relief in sight. The 3D Urologic's urinary device/system is far less expensive to manufacture.  it is also less expensive to implant (1 surgery instead of multiple surgeries).  the recovery time from our device is less. it virtually eliminates the following [insert Hanousek list]. our device is also applicable to both genders. it is capable of being customized to fit each patients needs  and finally our device/system can  be cleaned, maintained or repaired without additional surgeries. Cost cutting across the board, patient and caregiver centric make our device/systems very appealing to those who pay the bills (MEDICARE, MEDICAID, DoD, VA and PRIVATE INSURERS etc). To close, Boston Scientific paid Dr. Luis Palmaz $40 million for a rabbit with one implanted Stent. Imagine what a fully completed  invitro testing study might bring? We are willing to negotiate, please help us move forward.